TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Electrophysiological changes in facial muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Special Interest Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of nosocomial all-cause pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: AKI occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade 3 and higher peripheral neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Change in number of spontaneous bowel movements per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality of Life Scale in Epilepsy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Geometric mean titer (GMT) of neutralizing antibody to live SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety index-incidence of adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Ileal digestibility of protein and amino acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic accuracy of optical biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of shared health-related decision-making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preferences in role involvement in decision-making
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Barriers and facilitators of shared decision-making
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Percent change in TIR 70-180 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with % wear time >70%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in DTSQc scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: New onset of acute kidney failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: New onset of acute respiratory failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Per lesion dysplasia detection rate (DDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Per patient dysplasia detection rate (DDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Residents Who Meet Eligibility Criteria
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Residents who Consent
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Residents who Complete Assigned Intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Residents who Complete Assessments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ventilation/perfusion mismatch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of medical viscose-related skin injury
Endpoint domain: Adverse events/effects
Primary endpoint: Embryo morphology grade as evaluated by the SART grading system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vestibular evoked myogenic potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Side to side difference in laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of Emergency Department Visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of Referrals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: risk of recurrence or disease progression
Endpoint domain: Mortality/survival
Primary endpoint: tracheal tube extubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage change in worst itching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of total samples containing viable gonadal tissue and/or the presence of germ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Acceptability as a fertility preservation method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Regional Ventilation Delay (RDV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target triglyceride rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of grade 3/4 neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants meeting the primary net criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized severe asthma exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Explosive strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal dynamic force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to change direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in intima media thickness of carotid artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: geometric mean titer (GMT) of neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: geometric mean increase (GMI) of neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: seroconversion rates of neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Weight Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required for excision of hydrosalpinx
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Rates of bioprosthetic valve thrombosis detected by 4D-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of hepatitis B patients receiving guideline-based hepatitis B management by GP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of hepatitis B patients receiving specialist care in a hospital or private setting
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of hepatitis B patients receiving treatment by the GP in primary care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Referrals to tracing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intraoperative bleeding or oozing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Esophageal mechanical sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Esophageal chemical sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of blood pressure control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of blood glucose control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Finger independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog scale score postoperative
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Improvement in lower body muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in upper body muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Graft function measured by Glomerular Filtration Rate (GFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rheumatic valvular lesions rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with an all-cause readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Immunogenicity of a second booster
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Durable response achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps muscle layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage time of hypoventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Insulin sensitivity status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dynamic postural balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 hr cough frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients with inflammatory bowel disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change rate of lumbar bone mineral density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Geometric Mean Titer (GMT) of neutralizing antibody against Omicron SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Four-fold increase rate of neutralizing antibody against Omicron SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mGFR Iohexol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mGFR Iothalamate and hippuran
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Measurement of serum Sfrp-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measurement of serum Netrin-4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measurement of serum Resistin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood product volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Chest tube output blood volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with pulmonary hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Wear Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of diaphragm paralysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Applied forces on the manikin face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sputum Glucose Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Credibility/Expectancy and Satisfaction Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in IBS Symptom Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self-Reported IBS Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Self-Reported Perceptions of IBS Distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in primary clinical marker of inflammation IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of functional MRI (fMRI) parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knowledge of Firearm Injuries in the US
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Attitudes via Adapted Theory of Planned Behavior Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Intention to Use Behavioral Intervention Skills via Cook-Craig et al 2014
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Sensitivity of positional index in predicting post-spinal hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of intervention (ratings of e-coaches)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of intervention (helpfulness of peer interaction)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of intervention (accepting group invitation)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of intervention (engaging in the group)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of treatment emergency adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Performance on the Psychomotor Vigilance Task (PVT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of apnea/hypopnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants with postoperative stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Change of 6 minute walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of JVP assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference between oximeter SpO2 value and SaO2 value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Collection of biologic samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Level of Skin Pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of ischemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Na+, K+ and water content in the skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel movement pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of change of clinical and neurophysiological markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of change of anatomical and molecular markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4+ and CD8+ T cell absolute counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of image obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative chronic cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Receipt of sexually transmitted infection (STI) testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Perpetration of emotional abuse
Endpoint domain: Adverse events/effects
Primary endpoint: Expert clinical grading of efficacy attributes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of mesh reinforcement in laparotomy closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Blood serum AMH concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number and percentage of treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of prescription
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Empatic capacity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Absolute Change in Liver Fat Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WAT insulin sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Wakefulness After Sleep Onset
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Night time awakenings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: The composite index of anti-hypertensive drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in cognitive impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change in short and medium term memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline Standard physical performance battery score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of Stay (Days)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Environmental health literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of life-threatening events
Endpoint domain: Adverse events/effects
Primary endpoint: Birth of a living child beyond 28 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Bone specific alkaline phosphatase (BAP) modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Serious Adverse Event(s) (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Adverse Event(s) (AEs) Considered Related to Study Drug
Endpoint domain: Adverse events/effects
Primary endpoint: Reproducibility of breast shape
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sleep-wake rhythm
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Improvement in bowel related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: KOOS Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified MOAKS Cartilage Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Performance-technical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of unscheduled and uncoordinated care utilizations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall survival rate at 18 months
Endpoint domain: Mortality/survival
Primary endpoint: 3-year locoregional recurrence-free survival (LRFS)
Endpoint domain: Mortality/survival
Primary endpoint: Objective sleep quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving endoscopic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency, severity, and relatedness of treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency, severity, and relatedness of serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of RCS with timely ambulance dispatch
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Drinking Quantity/Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six Minute Walking Test (6MWT) distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Potentially clinically significant abnormalities (PCSAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of imaging in prostate cancer assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mental wellbeing of patients with dementia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in cognitive status of patients with dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in stress of health care providers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in correlated brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in lung cancer incidence
Endpoint domain: Mortality/survival
Primary endpoint: Change in lung cancer specific and overall mortality
Endpoint domain: Mortality/survival
Primary endpoint: Shift of gut microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Five Time Sit To Stand test completion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Allostatic Load Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of routine maternity care
Endpoint domain: Delivery of care
Primary endpoint: Percentage of Participants Achieving Systemic Lupus Erythematosus Responder Index (SRI-4) Response at Week 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence, Severity, and Frequency of Serious Adverse Events (SAEs) and Adverse Events (AEs)
Endpoint domain: Adverse events/effects